Haven't used LSK BioPharma yet?
Ask Trustburn

Questions about LSK BioPharma

Based on 10 reviews, listing data and website checks · updated 2 days ago

What is LSK BioPharma?

LSK BioPharma is a privately-held pharmaceutical company based in Salt Lake City, Utah, with offices in South San Francisco and Pangyo, South Korea. The company specializes in the clinical development of therapies for unmet medical needs in cancer. They are developing two proprietary drug candidates: rivoceranib (Apatinib), a VEGFR-2 inhibitor, and a BTK/JAK3 inhibitor for hematologic malignancies and rheumatoid arthritis. LSK BioPharma holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing.

What does the Trustburn rating split indicate about customer satisfaction?

The company's Trustburn rating is 4.2 out of 5 based on 10 reviews. The rating split includes five 5-star reviews, four 4-star reviews, and one 3-star review. These ratings reflect customer satisfaction with product quality and health improvements reported by users.

How long has LSK BioPharma existed and where are their offices located?

LSK BioPharma has been operating for at least a few years, as some reviewers have been loyal customers since the past few years. The company has established a presence with offices in Salt Lake City, South San Francisco, and Pangyo, South Korea, serving markets in the US and internationally.

What do reviewers commonly praise about LSK BioPharma?

Reviewers praise the company for offering high-quality products that have significantly improved their health and well-being. Many customers note that the products are effective, reasonably priced, and have made a positive impact on their quality of life.

What criticisms or areas for improvement do reviewers mention?

Some reviewers mention that there is room for improvement in the pharmaceutical industry's offerings from LSK BioPharma. One review specifically noted that while the quality is decent, the company could do a better job in certain areas.

How can customers order products from LSK BioPharma?

The company website, elevartherapeutics.com, is where customers can purchase products. Reviewers mention that delivery was prompt and shipping was fast when ordering from this site.

What types of products does LSK BioPharma offer?

LSK BioPharma offers a wide range of products that help improve well-being. The company is known for providing reliable and effective pharmaceutical solutions for various health concerns.

How can customers contact LSK BioPharma?

Customers can contact LSK BioPharma by calling the business phone number 8013037440. The company also provides customer service support for inquiries and orders.

Where is LSK BioPharma located?

The company is located at 8 E Broadway Ste 611 in Salt Lake City, Utah. This address serves as the primary contact point for the business in the US.

What is the official website of LSK BioPharma?

The official website of LSK BioPharma is elevartherapeutics.com.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="elevartherapeutics-com" data-lang="en"></div>
More widgets

About LSK BioPharma

LSK BioPartners, Inc (dba LSK BioPharma) is a privately-held pharmaceutical company based in Salt Lake City, Utah with offices in South San Francisco (and Pangyo, South Korea). LSK BioPharma (LSKB) specializes in clinical development of promising therapies for unmet medical needs in cancer. LSKB is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent. LSKB holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.

Address
8 E Broadway Ste 611